Compare Boston Scientific Corporation (BSX) vs Iron Mountain Inc (IRM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Boston Scientific Corporation vs Iron Mountain Inc — how do they compare? Boston Scientific Corporation trades at $42.62 (market cap $66.37B), while Iron Mountain Inc trades at $122.4 (market cap $36.49B). The key difference: Boston Scientific Corporation is the larger of the two by market cap, and Iron Mountain Inc pays a 2.82% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | IRM | |
|---|---|---|
Market Cap | $66.37B | $36.49B |
Sector | Health | Real Estate |
52-Week High | $108.14 | $133.06 |
52-Week Low | $42.63 | $78.86 |
Enterprise Value | $75.94B | $55.63B |
Dividend Yield | — | 2.82% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Boston Scientific (BSX) trades at $44.65, down 0.27% with bearish technical signals despite strong fundamentals. The company delivered three consecutive earnings beats with Q3-Q1 2026 EPS exceeding expectations, while revenue grew to $20.07B in 2025 with improving profit margins. Technical indicators show bearish momentum with support at $44 and resistance at $45, though Wall Street maintains 88% buy rating with $70.20 consensus target.
BSX presents a compelling value opportunity with attractive valuation multiples (P/E 18.68, P/S 3.24) and robust financial health, though near-term headwinds include competitive pressures in key segments and recent stock price decline of nearly 60% from 2025 highs. The strong analyst consensus suggests significant upside potential if execution improves.
Iron Mountain (IRM) trades at $122.37, up 0.72% on the day, showing strong momentum with a 30.2% gain over three months. The stock is in a bullish technical trend, supported by recent earnings beats and positive analyst sentiment. Revenue growth accelerated to $6.90 billion in 2025, though net margins remain thin at 3.76%. Recent news highlights its data center strength and a $1.5 billion debt offering to fund expansion.
Outlook is cautiously optimistic with a consensus price target of $138.67 offering 13% upside. Risks include high debt levels (debt-to-asset ratio of 79.04% in 2025) and margin pressure. The stock appeals for its growth exposure and dividend yield, but investors should weigh leverage concerns against operational momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →About Iron Mountain Inc
Iron Mountain Inc is a record management services provider. The firm is organized as a REIT. Most of its revenue comes from its storage business, with the rest coming from value-added services. The firm primarily caters to enterprise clients in developed markets. Its business segments include Global RIM Business
Read more on IRM →
